IPCA Laboratories

BSE : 524494 | NSE : IPCALAB

Industry : Pharmaceuticals | ISIN : INE571A01020 | FreeFloat : 55.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)8,296.32
Net Worth (NW)3,641.11
Intrinsic Worth (IW)11,937.43
Market Cap (MC)17,591.37
Economic Value Added-23.97
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)69.50%
IC Gross Margin (EBITDA/IC)12.40%
IC Net Margin (NPT/IC)8.37%
Knowledge Turnover (Sales/IC)0.58
Market to Intrinsic Value (MC/IW)1.47

As OfIntrinsic ValueMarket Price
31 Mar 2020Rs. 944.78Rs. 1,392.25
3 Aug 2020 - Rs. 1,888.35
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : NoSell10 DMA : Rs. 1,783.39BuyHold
KB > 50% : Yes50 DMA : Rs. 1,653.82
0 < M2IV < 1 : NoVol-Price trend : Rising

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-17
S
712.96
719.14
27.70
-15.64
-21.22
-20.25
-17.64
Sep-17
S
864.29
875.29
160.03
115.98
109.59
96.47
95.91
Dec-17
S
859.21
870.18
172.17
128.35
122.75
105.58
102.46
Mar-18
S
782.75
794.14
121.28
78.13
71.68
51.31
53.95
Jun-18
C
889.75
889.75
132.87
86.30
81.37
68.30
68.55
Sep-18
C
1012.00
1026.76
174.29
128.94
141.32
119.22
118.54
Dec-18
C
1006.14
1019.48
234.46
188.72
196.94
159.52
159.19
Mar-19
C
879.61
894.87
164.58
119.82
128.64
96.99
98.55
Jun-19
C
1078.19
1098.53
198.72
152.62
168.37
131.02
129.63
Sep-19
C
1283.90
1298.70
265.86
216.23
226.80
194.91
193.07
Dec-19
C
1212.86
1230.99
273.66
222.83
236.95
200.06
197.61
Mar-20
C
1073.76
1087.49
179.86
115.92
112.25
83.05
84.14
* C - Consolidated, S - Standalone